Dyne Therapeutics Inc (DYN) Insider Trading
- $43,295,935.73
- $760,029,580.25
- Oct. 16, 2024
- Franklin Resources Inc
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 16, 2024 | Director | 23,671 | $35.35 | Sell | $836,769.85 | |
Sept. 25, 2024 | Director | 2,357 | $35.06 | Sell | $82,636.42 | |
Sept. 23, 2024 | Director | 40,831 | $35.32 | Sell | $1,442,150.92 | |
Sept. 20, 2024 | Director | 79,411 | $36.45 | Sell | $2,894,530.95 | |
Sept. 18, 2024 | COO | 8,976 | $34.41 | Sell | $308,864.16 | |
Sept. 18, 2024 | SVP | 1,390 | $34.55 | Sell | $48,024.50 | |
Sept. 18, 2024 | Insider | 2,339 | $34.55 | Sell | $80,812.45 | |
Sept. 4, 2024 | CEO | 32,000 | $33.04 | Buy | $1,057,280.00 | |
June 24, 2024 | COO | 10,163 | $35.33 | Sell | $359,058.79 | |
June 21, 2024 | COO | 29,787 | $35.01 | Sell | $1,042,842.87 | |
June 12, 2024 | COO | 40,000 | $33.36 | Sell | $1,334,400.00 | |
June 11, 2024 | Insider | 2,136 | $31.34 | Sell | $66,942.24 | |
June 10, 2024 | SVP | 1,590 | $30.23 | Sell | $48,065.70 | |
June 10, 2024 | COO | 80,000 | $30.24 | Sell | $2,419,200.00 | |
May 20, 2024 | Insider | 30,426 | $32.96 | Sell | $1,002,840.96 | |
May 16, 2024 | COO | 2,738 | $28.27 | Sell | $77,403.26 | |
May 16, 2024 | SVP | 2,588 | $28.27 | Sell | $73,162.76 | |
May 16, 2024 | Insider | 2,705 | $28.27 | Sell | $76,470.35 | |
March 11, 2024 | COO | 2,292 | $25.70 | Sell | $58,904.40 | |
March 11, 2024 | SVP | 2,672 | $25.28 | Sell | $67,548.16 | |
March 11, 2024 | CEO | 66,387 | $25.67 | Sell | $1,704,154.29 | |
March 11, 2024 | Insider | 1,585 | $25.70 | Sell | $40,734.50 | |
March 7, 2024 | COO | 1,591 | $25.85 | Sell | $41,127.35 | |
March 7, 2024 | SVP | 2,273 | $25.85 | Sell | $58,757.05 | |
March 7, 2024 | Insider | 2,373 | $25.85 | Sell | $61,342.05 | |
March 7, 2024 | CEO | 9,086 | $25.85 | Sell | $234,873.10 | |
Feb. 29, 2024 | SVP | 3,429 | $27.50 | Sell | $94,297.50 | |
Feb. 29, 2024 | CEO | 5,520 | $27.50 | Sell | $151,800.00 | |
Feb. 29, 2024 | Insider | 4,268 | $27.50 | Sell | $117,370.00 | |
Feb. 28, 2024 | Director | 190,920 | $24.84 | Sell | $4,742,452.80 | |
Feb. 28, 2024 | Major Shareholder | 154,674 | $24.84 | Sell | $3,842,102.16 | |
Feb. 26, 2024 | Major Shareholder | 201,095 | $23.72 | Sell | $4,769,973.40 | |
Feb. 26, 2024 | Director | 248,219 | $23.72 | Sell | $5,887,754.68 | |
Feb. 23, 2024 | Major Shareholder | 159,542 | $22.70 | Sell | $3,621,603.40 | |
Feb. 22, 2024 | Director | 119,360 | $22.66 | Sell | $2,704,697.60 | |
Feb. 21, 2024 | Major Shareholder | 184,501 | $22.57 | Sell | $4,164,187.57 | |
Feb. 20, 2024 | Director | 169,539 | $22.72 | Sell | $3,851,926.08 | |
Feb. 16, 2024 | Major Shareholder | 162,707 | $23.14 | Sell | $3,765,039.98 | |
Feb. 15, 2024 | Director | 177,906 | $23.89 | Sell | $4,250,174.34 | |
Feb. 12, 2024 | Insider | 5,493 | $25.07 | Sell | $137,709.51 | |
Jan. 26, 2024 | Insider | 100 | $25.00 | Sell | $2,500.00 | |
Jan. 26, 2024 | SVP | 13,000 | $24.34 | Sell | $316,420.00 | |
Jan. 9, 2024 | Director | 1,714,285 | $17.50 | Buy | $29,999,987.50 | |
June 15, 2023 | Insider | 10,000 | $12.03 | Sell | $120,300.00 | |
June 13, 2023 | COO | 1,625 | $12.43 | Sell | $20,198.75 | |
June 12, 2023 | Insider | 187,748 | $12.61 | Sell | $2,367,502.28 | |
June 9, 2023 | Insider | 76,582 | $13.34 | Sell | $1,021,603.88 | |
March 14, 2023 | COO | 1,559 | $13.33 | Sell | $20,781.47 | |
March 14, 2023 | Insider | 1,311 | $13.33 | Sell | $17,475.63 | |
Jan. 18, 2023 | Insider | 10,000 | $14.03 | Sell | $140,300.00 |
Insiders are both buying and selling Dyne Therapeutics Inc stock.
The insider traders at Dyne Therapeutics Inc are: Franklin Resources Inc, Susanna Gatti High, Richard William Scalzo, Joshua T Brumm, Jason P Rhodes, Dirk Kersten, Venture Fund Xi L.P. Atlas, Oxana Beskrovnaya, Wildon Farwell, Robert C Flexon, Robert C. Flexon, Jonathan Mcneill, Clint Freeland, Martin W Daley, Hilary E Ackermann, Patrick Wood III, Paul M Barbas, Henry D Jones, Ecp Controlco, Llc, Daniel P Thompson, John Cox, Jeffrey Scott Stein, and Mario E Alonso
The most active insider trader at Dyne Therapeutics Inc is Franklin Resources Inc with 100 trades.
Franklin Resources Inc has sold the most Dyne Therapeutics Inc stock with a total value of $642,516,995.93.
Dirk Kersten has bought the most Dyne Therapeutics Inc stock with a total value of $59,999,975.00.
The most recent insider trade for Dyne Therapeutics Inc was on Oct. 16, 2024.
The single biggest insider buy for Dyne Therapeutics Inc was from Dirk Kersten with a total value of $29,999,987.50 on Jan. 9, 2024.
The single biggest insider sell for Dyne Therapeutics Inc was from Ecp Controlco, Llc with a total value of $61,897,500.00 on Jan. 9, 2018.